Postdoctoral fellowships

Awarded fellowships

Edition 2022-2023

Oriol Dols-Icardo

Sant Pau Biomedical Research Institute, Down Unit (UAD), Barcelona. Spain
Assessing the role of the peripheral immune system in the Down Syndrome population at different stages of Alzheimer’s Disease using single-cell RNA sequencing

Lisi Flores Aguilar

University of California, Irvine. United States
Pathology and proteomics of the brain vascular system across the lifespan of individuals with Down syndrome

Tomer Illouz

Brigham and Women’s Hospital, Center for Neurologic Diseases, Boston. United States
Neuroimmune Connectome Perturbations in Trisomy-21-Related Alzheimer’s Disease

Sergi Llambrich Ferre

Universitat de Barcelona. Spain
Testing a preclinical mouse model to investigate how upper airway malformations are associated with cognitive impairment and respiratory infections in Down syndrome

Aurore Thomazeau

Institut de Pharmacologie Moléculaire et Cellulaire, CNRS UMR7275, Valbonne. France
Unconventional NMDAR signaling: a new axis in the synaptic pathophysiology of cognitive disability associated with Down syndrome and Fragile X syndrome

Edition 2021-2022

Asaad Baksh

King’s College London, London. United Kingdom
Understanding unique health needs to inform personalised treatment: multimorbidity and clusters of long-term health conditions in people with Down syndrome compared to the general population and people with other intellectual disabilities

Pasquale D’Acunzo

Research Foundation for Mental Hygiene Inc. at the Nathan S. Kline Institute for Psychiatric Research. New York. United States
Elucidating the role of mitovesicles, newly identified extracellular vesicles of mitochondrial origin, in the propagation of mitochondrial dysfunction in Down syndrome

Anna Moyer

University of Alabama at Birmingham. Unites States
HMGN1 as a Mediator of Dysregulated Sonic Hedgehog Signalling and Autism Risk in Down Syndrome

Alexia Tiberi

Scuola Normale Superiore, Pisa. Italy
Microglial cells as contributors to the excitatory/inhibitory balance: a key to understanding epileptic prevalence in Down Syndrome  

Edition 2020-2021

Melody Atkins

Institut du Fer à Moulin. Paris, France

Primary cilium-dependent cortical interneuron migration in Down Syndrome mouse models

Daniella Balduino Victorino

Institut du Cerveau et de la Moelle Epinière. Paris, France

Elucidating the effects of age-related and tissue-specific modulation of DYRK1A expression on Alzheimer’s disease-like pathology in mice

René Crans

Centre for Genomic Regulation. Barcelona, Spain

Stratifying Cognitive Improvements to Reveal the Effect of Allelic Diversity in Trisomy 21

Nakisa Malakooti

Monash University. Clayton, Australia

Understanding how gene interactions in Down syndrome impacts cognitive decline; structure to function relationships in brains

Nunzia Mollo

University of Naples Federico II. Naples, Italy

Defects in mitophagy and mitochondrial activity as key determinants of Alzheimer’s disease in Down Syndrome: novel therapeutic strategies

Ilaria Colombi

Fondazione Istituto Italiano di Tecnologia. Genova, Italy

Early NKCC1 Inhibition to treat epilepsy and hyperactivity in Down syndrome  

Birger Tielemans

KU Leuven. Leuven, Belgium

Cardiopulmonary-vascular disorders in Down syndrome research: a long-overlooked issue

Edition 2019-2020

Javier Aguado Perez

University of Queensland. Brisbane, Australia

Elucidating the genetic drivers of accelerated cellular ageing in Down syndrome

Carlos Aya-Bonilla

University of Western Australia. Perth, Australia

Down syndrome-Acute lymphoblastic leukaemia (DS-ALL): A model to unravel the molecular mechanisms underlying treatment-resistance in paediatric leukaemia”

*Co-financed by Fondation Sisley-D’Ornano     

Aoife Murray

Blizzard Institute. Queen Mary University of London. London, United Kingdom

Assessment of specific biological features of trisomy 21 neurons, affecting cell-cell transmission of Alzheimer’s pathology using cerebral organoids

Javier Zorrilla De San Martin

Institut du Cerveau et de la Moelle Epinière. Paris, France

Role of PFC SST+ interneurons on emotional state recognition in a mouse model of Down syndrome

Edition 2018-2019

Marta Fructuoso Castellar

Institut du Cerveau et de la Moelle Epinière. Paris, France

Uncovering the signaling pathways to neurodegeneration of the locus coerulus, and cognitive impairments in Down syndrome

*Co-financed by Fondation Sisley-D’Ornano       

Elsa Pittaras

Stanford University. Stanford, United States

Usp16 as a new therapeutic target in Alzheimer disease and Down syndrome

Edition 2017-2018

Maria Victoria Hinckelmann Rivas

Institut de Génétique et de Biologie Moléculaire et Cellulaire. Illkirch, France

Role of DYRK1A in GABAergic inhibitory neurons development, impact on the excitatory/inhibitory balance in diseases with intellectual disabilities

*Co-financed by Fondation Sisley-D’Ornano    

Florencia Iulita

Hospital de la Santa Creu i Sant Pau. Barcelona, Spain

Discovery of novel biomarkers signaling NGF metabolic dysfunction and early AD-dementia in Down syndrome

Edition 2016-2017

Ioannis Sotiropoulos

Life and health science research institute. University of Minho. Braga, Portugal

Tau therapeutics in Down syndrome & Alzheimer’s disease brain pathologies

*Co-financed by Fondation Sisley-D’Ornano